Development Pipeline

Today, our research efforts are dedicated to advancing a diverse pipeline of innovative therapies for solid tumors and blood-related cancers.
Learn about our development programs by selecting an agent below or click to explore our interactive pipeline.


a highly selective small molecule tyrosine kinase inhibitor being investigated in multiple HER2-overexpressed/amplified and HER2-mutated cancers

  • Phase 2
  • Phase 3

View Program